First-ever INTERCEPT pathogen-reduced platelet units produced in US

Cerus Corp. and the SunCoast Blood Bank (SCBB) recently announced that they have produced the first pathogen-reduced platelet units within the U.S. Read More »

CDC committee votes to allow meningococcal group B vaccine

Newly available vaccinations to combat the “B” strain of meningitis should only be considered for use by individuals and their physicians, recommends the Advisory Committee on Immunization Practices, a committee of the U.S. Centers for Disease Control and Prevention. Read More »

Cellular Biomedicine Group acquires GVAX vaccine

Cellular Biomedicine Group Inc., a biomedicine company that focuses on creating new treatments for cancerous and degenerative diseases, recently announced that it has acquired the CD40LGVAX vaccine from Blackbird Bio Finance and the University of Florida. Read More »

Scripps team studies new treatments for Marburg virus

A team of scientists from the Scripps Research Institute (SRI) recently conducted a study to identify noel immune molecules to protect people against Marburg virus, which is related to Ebola. Read More »

Researchers evaluate genetic war between mosquitoes and humans

Researchers have stated that approximately 5 to 20 percent of a mosquito population’s genome is adaptable to evolutionary pressures at all times, which makes it more likely to adapt to local humans and environments. Read More »

Xenex robots reduce infections by disinfecting rooms

Xenex Germ-Zapping Robots disinfect rooms so efficiently that multiple hospitals have stated that their infections rates have decreased thanks to the new technology. Read More »

Maryland researchers report decoy molecule may decrease flu deaths

A scientist from the University of Maryland School of Medicine recently identified a “decoy” molecule that may be crucial to reducing the risk of flu deaths each year. Read More »

SB 277 would end some families' personal belief exemptions for vaccines

The full assembly recently passed Senate Bill 277, legislation designed to end the personal belief exemption for vaccines in California. Read More »

Immunovaccine launches clinical trial for DPX-RSV vaccine

Immunovaccine, Inc., a Nova Scotia-based clinical stage vaccine and immunotherapy company, said Tuesday the first healthy volunteer has enrolled in the Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine. Read More »

Innovative sequencing successfully detects resistant pathogens

Kalorama Information, a healthcare market researcher, recently reported that next-generation sequencing may allow researchers to bypass the negative qualities of molecular testing, placing sequencing in an important role for clinical tests. Read More »

BiondVax sees positive results in M-001 flu vaccine clinical trial

BiondVax Pharmaceuticals, Ltd. said Monday that preliminary results are positive for its BVX-006 Phase II clinical trial for the company’s universal influenza vaccine candidate M-001. Read More »

Equatorial Guinea agrees to malaria vaccine development program

The Republic of Equatorial Guinea agreed to sponsor clinical development and trials of Sanaria, Inc's PfSPZ malaria vaccine with three oil companies on Monday. The agreement calls for Equatorial Guinea and partners AMPCO, Marathon Oil Corp. and Noble Energy, Inc. to invest $48.5 million to support Sanari efforts to develop and license the vaccine. Read More »

Replicor reveals clinical trial data at Global Virus Hepatitis Summit

Replicor Inc., a privately owned biopharmaceutical company that focuses on creating cures for people with chronic hepatitis B (HBV) infections and hepatitis D (HDV) infections, recently announced that a representative will present updated clinical data from its REP 301 clinical trial at the Global Virus Hepatitis Summit. Read More »

Marken provides direct shipments for MERS outbreak patients

Marken, a leading clinical trial logistics organization that offers services and solutions to the life sciences industry, recently gained government approval to provide the first direct-to-patient shipment of treatments to South Korea for the Middle East Respiratory System (MERS) outbreak. Read More »